From professional translators, enterprises, web pages and freely available translation repositories.
alemtuzumab causes the lysis of lymphocytes by binding to cd52, a highly expressed, non- modulating antigen which is present on the surface of essentially all b and t cell lymphocytes as well as monocytes, thymocytes and macrophages.
alemtuzumab veroorzaakt de lysis van lymfocyten door binding aan cd52, een sterk tot expressie komend, niet-modulerend antigeen dat aanwezig is op het oppervlak van in wezen alle b- en t- cellymfocyten evenals monocyten, thymocyten en macrofagen.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
